The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: Interim results from a phase Ib study.
 
Andrea Varga
No Relationships to Disclose
 
Sarina Anne Piha-Paul
Research Funding - Biomarin; GlaxoSmithKline; Helix BioPharma; Merck; Novartis; Puma Biotechnology
 
Patrick Alexander Ott
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; Bristol-Myers Squibb; Merck
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen
 
Dominique Berton-Rigaud
No Relationships to Disclose
 
Elizabeth A. Johnson
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jonathan D. Cheng
Employment - Merck Sharp & Dohme
Leadership - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Sammy Yuan
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Eric H. Rubin
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
 
Daniela E. Matei
No Relationships to Disclose